Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells

Biosci Biotechnol Biochem. 2005 Feb;69(2):307-14. doi: 10.1271/bbb.69.307.

Abstract

Overexpression of matrix metalloproteinases (MMPs) is associated with cancer metastasis. We assessed mRNA expression of MMPs in six human colorectal cancer cell lines and found a considerable level of MMP-7 expression in HT-29 cells. Next, we searched for natural and synthetic compounds that cause a reduction in the production of proMMP-7 protein, and found that nobiletin (NOB), quercetin, valeryl salicylate, and sulindac sulfone demonstrated marked inhibition. Importantly, NOB attenuated proMMP-7 protein and its mRNA expression both concentration- and time-dependently via a reduction of activator protein-1 (AP-1) DNA binding activity, suggesting it as a promising agent for suppression of cancer cell invasion and metastasis through MMP-7 gene repression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colorectal Neoplasms / enzymology*
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Flavones / pharmacology*
  • Gene Expression Profiling
  • HT29 Cells
  • Humans
  • Matrix Metalloproteinase 7 / metabolism*
  • RNA, Messenger / metabolism
  • Time Factors
  • Transcription Factor AP-1 / metabolism

Substances

  • Flavones
  • RNA, Messenger
  • Transcription Factor AP-1
  • nobiletin
  • Matrix Metalloproteinase 7